The WSMI Board has approved and issued a position statement on so-called ‘electronic cigarettes’. WSMI supports pharmacotherapy only where scientific studies demonstrate predictable outcomes under specified conditions and when products have been approved as safe and effective by medicines regulatory agencies. By contrast, electronic nicotine delivery systems such as electronic cigarettes are not endorsed or registered as medicines and lack scientific evidence supporting their use. WSMI believes that electronic nicotine delivery systems and any other product containing nicotine must be properly reviewed and regulated in the interests of consumer safety. WSMI believes that there is a strong case to ban unregistered electronic nicotine delivery devices, which have given rise to a number of concerns including strong concerns that they may deliver highly inconsistent and irregular dosing. WSMI therefore calls upon national authorities to carry out market surveillance and enforcement activities to ensure that only safe products are put on the market and to suspend marketing of products for which no safety evaluations have been made.
For the full statement please click here.